Morgan Craig - Concepedia

Author

Morgan Craig

Université de Montréal ORCID

Also Known As

Amanda P. Smith, Craig Morgan, Craig, Morgan, M CRAIG, M Craig, M. Craig, Morgan Craig, Xiaoyan Deng, Yale S. Michaels

Publications

1.8K

Citations

H-Index

101

Concepts

All Affiliations

Université de Montréal Centre Hospitalier Universitaire Sainte-Justine McGill University Harvard University University of Alberta

About

Morgan Craig is an author at Université de Montréal specializing in medicine, immunology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	22	992
2	Health Sciences	5	5	373
3	Engineering	4	4	149
4	Public Health	1	1	89
5	Biomedical Engineering	1	1	70

Morgan Craig

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Increased stem cell proliferation in atherosclerosis accelerates clonal hematopoiesis Alexander Heyde, David Rohde, Cameron S. McAlpine, Cell MedicineHematologyStem Cell ResearchVascular BiologyStem Cell Proliferation	2021	245
Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy Ameya R. Kirtane, Omar Abouzid, Daniel Minahan, Nature Communications	2017	224
Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial Drew J. Winston, Kathleen M. Mullane, Oliver A. Cornely, The Lancet VaccinationTransplantationMarrow TransplantationVaccine DevelopmentVaricella Zoster Vaccine	2018	93
COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes Adrianne L. Jenner, Rosemary A. Aogo, Sofia Alfonso, PLoS Pathogens Robust Ifn ResponsesVirtual PatientsImmunologyImmunologic MechanismCd4 T Cell Responses	2021	89
Iterative community-driven development of a SARS-CoV-2 tissue simulator Michael Getz, Yafei Wang, Gary An, EngineeringDisease Modeling (Infectious Disease Modeling)Medical ImagingEmerging Infectious DiseasesNovel Coronavirus	2020	70
Determinants of combination GM-CSF immunotherapy and oncolytic virotherapy success identified through in silico treatment personalization Tyler Cassidy, Morgan Craig PLoS Computational Biology ImmunodeficienciesImmunologyImmunoeditingPathologyImmunotherapeutics	2019	61
Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex Chapin S. Korosec, Suzan Farhang‐Sardroodi, David W. Dick, Scientific Reports	2022	52
Bispecific monoclonal antibody complexes facilitate erythrocyte binding and liver clearance of a prototype particulate pathogen in a monkey model Ronald P. Taylor, Edward N. Martin, Michele L. Reinagel, The Journal of Immunology	1997	47
In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity Adrianne L. Jenner, Tyler Cassidy, Katia Belaid, Journal for ImmunoTherapy of Cancer	2021	46
Agent-based computational modeling of glioblastoma predicts that stromal density is central to oncolytic virus efficacy Adrianne L. Jenner, Munisha Smalley, David Goldman, iScience	2022	44

Page 1